Internal Medicine, Hematology & Oncology · Kissimmee, FL
NPI
1558339796
Since 2006
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
737 West Oak Street
Kissimmee, FL, 34741
Phone (407) 933-2775
Groups this clinician bills Medicare through
Medicare paid, 2024
$12K
1,540 services
Medicare patients, 2024
61
Average age 76
Drug cost, 2024
$6.1M
1,043 prescriptions
Company payments, 2024
$916
From 22 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jorge G Otoya was code 99214 (office e&m - established), 52 times for 47 patients. In total Jorge G Otoya billed 1,540 services in 27 codes, and Medicare paid $12K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-12-19.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 52 | 47 | $68.10 | $3,541 |
| 36415 Venipuncture Blood Collection | Office | 43 | 23 | $8.65 | $372 |
| 85025 Blood Count | Office | 40 | 23 | $7.61 | $304 |
By year: 2022 $67K for 2,223 services; 2023 $61K for 5,728 services; 2024 $12K for 1,540 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 43 | 23 | $8.65 | $372 |
| 85025 Blood Count | 40 | 23 | $7.61 | $304 |
Medicare prescription drug claims, 2024
In 2024, the drug Jorge G Otoya prescribed most often to Medicare patients was Dexamethasone, with 72 prescriptions and refills. In total Jorge G Otoya wrote 1,043 Medicare prescriptions that cost $6.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Dexamethasone Generic | 72 | 72 | 11 | $683 |
| Letrozole Generic | 70 | 166 | 22 | $1,251 |
| Lenalidomide Generic | 43 | 43 | Under 11 | $578K |
| Procrit Epoetin Alfa | 42 | 42 | Under 11 | $83K |
| Tamoxifen Citrate Generic | 42 | 78 | 11 | $1,305 |
| Hydroxyurea Generic | 38 | 72 | 12 | $1,395 |
| Exemestane Generic | 36 | 68 | Under 11 | $4,661 |
| Retacrit Epoetin Alfa-Epbx | 33 | 33 | Under 11 | $12K |
| Tasigna Nilotinib Hcl | 32 | 32 | Under 11 | $643K |
| Imatinib Mesylate Generic | 30 | 30 | Under 11 | $12K |
| Valacyclovir Valacyclovir Hcl | 30 | 40 | Under 11 | $1,052 |
| Pomalyst Pomalidomide | 29 | 29 | Under 11 | $645K |
| Prolia Denosumab | 27 | 156 | 16 | $47K |
| Reblozyl Luspatercept-Aamt | 25 | 25 | Under 11 | $283K |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 25 | 25 | Under 11 | $280 |
Brand drugs: 463 claims; generic drugs: 580 claims; opioid claims: 36.
Money and other things of value reported by the companies
In 2024, drug and medical device companies paid Jorge G Otoya $916 ($916 in general payments such as food, travel and fees) from 22 companies. The largest payer was Novartis Pharmaceuticals Corporation with $157.
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation NVS | 7 | $157 |
| Pfizer Inc. PFE | 9 | $134 |
| Genzyme Corporation SNY | 3 | $87.75 |
| Celgene Corporation BMY | 3 | $70.96 |
| BeiGene USA, Inc. ONC | 3 | $54.01 |
| Gilead Sciences, Inc. GILD | 2 | $48.4 |
| GlaxoSmithKline, LLC. GSK | 2 | $43.08 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 2 | $40.45 |
| Abbvie Inc. ABBV | 1 | $34.49 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 1 | $26.08 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.